ICMR Gets Approval for Plasma Therapy for COVID-19 Treatment

The Indian Council of Medical Research (ICMR) will conduct trial in 21 hospitals to assess safety and efficacy of convalescent plasma on COVID-19 patients.

The Indian Council of Medical Research (ICMR) has got approval from the National Ethics Committee for the trial of convalescent plasma therapy to assess its effectiveness in the treatment of COVID-19.

Speaking at a press conference, Joint Secretary of the Union Health Ministry Lav Agarwal said, "ICMR has received approval for Project PLACID - Phase-II Open-Label Randomized Controlled Trial from the COVID-19 National Ethics Committee."

KGMU Hospital Starts Plasma Therapy to Treat COVID-19
Convalescent plasma therapy was started on the critical patient by doctors of King George's Medical University (KGMU), Lucknow in their fight against COVID-19.

TOP INSIGHT

The Indian Council of Medical Research (ICMR) will conduct trial in 21 hospitals to assess safety and efficacy of convalescent plasma on COVID-19 patients.

The 21 hospitals include 5 hospitals from Maharashtra, 4 from Gujarat, 2 hospitals each from Rajasthan, Tamil Nadu, Madhya Pradesh and Uttar Pradesh and 1 hospital each in Punjab, Karnataka, Telangana and Chandigarh.

The convalescent plasma therapy aims at using antibodies from the blood of a recovered Covid-19 patient to treat those critically affected by the virus. As on Friday a total of 16,539 people have defeated novel coronavirus and have recovered from the disease. The recovery rate has improved to 29.36 per cent, said Agarwal.

The total tally of novel coronavirus cases in India stood at 56,342 including 3,390 new cases and 103 new fatalities.

Plasma Therapy Seems Successful To Fight Corona Virus
Plasma therapy results being positive in curing the coronavirus infected, the national capital is hopeful of recovering from the crisis.

Source-IANS

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.